Literature DB >> 32135551

Outcomes of the treatment of trigger digits by extracorporal shock wave therapy (ESWT).

Andrzej Zyluk1, Hanna Mosiejczuk2.   

Abstract

BACKGROUND: Currently, extracorporal shock wave therapy (ESWT) has been widely used in tendinopathies, including trigger fingers.
PURPOSE: The objective of this study was evaluation of effectiveness of ESWT for trigger digits in a short and mid-term follow-up. PATIENTS AND METHODS: Thirty-two patients, 28 women and 4 men, in a mean age of 60 years, with a total of 50 affected digits underwent local extracorporal shock wave treatment. Each patient received 3 applications in a weekly interval. Results were assessed at 1 week and 3 months follow-up, using numeric rank scale for pain and Froimson scale for clinical severity.
RESULTS: One-week post-treatment, pain and triggering ceased completely or reduced significantly in 30 patients (94%). At 3 month follow-up, in 30 patients (94%) the symptoms resolved completely and they were considered recovered. Two patients (6%) failed to improve and in these cases the treatment was considered ineffective.
CONCLUSION: ESWT is an effective therapy for trigger digits in II° i III° severity grade and may be an alternative for other, noninvasive measures such as physiotherapy or steroid injection. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32135551     DOI: 10.1055/a-1111-8892

Source DB:  PubMed          Journal:  Handchir Mikrochir Plast Chir        ISSN: 0722-1819            Impact factor:   1.018


  2 in total

1.  Use of a Percutaneous Needle Release Technique for Trigger Thumb: A Retrospective Study of 11 Patients from a Single Center.

Authors:  Xianjie Sun; Haidong Wang; Xingen Zhang; Bangjian He
Journal:  Med Sci Monit       Date:  2021-10-07

2.  Clinical Utility of Extracorporeal Shock Wave Therapy on Hypertrophic Scars of the Hand Caused by Burn Injury: A Prospective, Randomized, Double-Blinded Study.

Authors:  So Young Joo; Seung Yeol Lee; Yoon Soo Cho; Cheong Hoon Seo
Journal:  J Clin Med       Date:  2020-05-07       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.